Conference Description:
IBC’s 4 th Vaccines China 2012 is timely and has been researched with the industry to provide the most comprehensive event focused on vaccines development through to manufacturing. Good manufacturing practices and strategies will be reviewed, alongside potential block-buster technologies and R&D projects.
This conference is co-located with the 7 th annual China Pharmaceutical R&D Summit and 3 rd annual Biosimilars Asia conference to maximize cross-learning, partnering and networking opportunities with biopharma and related industries.
5 top reasons to attend
1.Gain insights into quality and compliance strategies by international and local vaccines manufacturers.
2.Identify prospective research projects and technologies for strategic collaborations.
3.Evaluate opportunities currently present in the vaccines market and its relevant risks.
4.Benchmark your manufacturing practices and policies against the leading players in the industry.
5.Assess future trends and the next generation of vaccines
What’s new in 2012?
1.SHOWCASE latest research findings and new technologies in the vaccines development
2.NEW focus on quality and compliance strategies to meet WHO pre-qualifications and new GMP
3.Highlight advances and collaborations in China’s high-growth market
4.DETAILED analysis on existing and upcoming opportunities in China and beyond
5.Co-located with the 7th annual China Pharmaceutical R&D Summit and 3 rd annual Biosimilars Asia conference to maximize cross-learning, partnering and networking opportunities
Start Date: 2012-04-23
Last Day: 2012-04-26
Contact Person: Rita Parasurum
Email: register@ibcasia.com.sg
Address:
Grand Hyatt Shanghai, Shanghai, Singapore
Tel: 6565082401 / 862123263680
;)
